Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $12.7500 (-2.3%) ($12.7500 - $13.0350) on Thu. Sep. 22, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.1% (three month average) | RSI | 35 | Latest Price | $12.7500(-2.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.1% a day on average for past five trading days. | Weekly Trend | BCRX declines -2.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLK(33%) URA(32%) VT(32%) VUG(32%) BLOK(30%) | Factors Impacting BCRX price | BCRX will decline at least -2.05% in a week (0% probabilities). VIXM(-15%) UUP(-14%) SMH(-11%) VXX(-3%) TLT(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.05% (StdDev 4.1%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $6.28(-50.75%) | Resistance Level | $13.6 | 5 Day Moving Average | $13.18(-3.26%) | 10 Day Moving Average | $13.24(-3.7%) | 20 Day Moving Average | $13.6(-6.25%) | To recent high | -14% | To recent low | 34.2% | Market Cap | $2.249b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |